Bernard Taylor

Cambridge Laboratories is a fast growing, dynamic and entrepreneurial pharmaceutical company with extensive product development and commercialization expertise. Their focus is on specialist pharmaceuticals with core products in Oncology and diseases of the central nervous system (CNS). They have a proven track record in the development, global registration, marketing, sales and distribution of both innovative and well established pharmaceutical products. This combined with its strong product portfolio and their ability to forge lasting relationships with global partners, has helped them generate substantial sales growth over the past 13 years. They are proud of its independence and entrepreneurial culture. Equally, their strong balance sheet and freedom from debt give them a solid foundation from which they continue to enhance its growth. Cambridge Laboratories is an independent and privately owned company, founded in 1987 and purchased outright by members of the current Board of Directors in 1996.

Cambridge Laboratories is a fast growing, dynamic and entrepreneurial pharmaceutical company with extensive product development and commercialization expertise. Their focus is on specialist pharmaceuticals with core products in Oncology and diseases of the central nervous system (CNS). They have a proven track record in the development, global registration, marketing, sales and distribution of both innovative and well established pharmaceutical products. This combined with its strong product portfolio and their ability to forge lasting relationships with global partners, has helped them generate substantial sales growth over the past 13 years. They are proud of its independence and entrepreneurial culture. Equally, their strong balance sheet and freedom from debt give them a solid foundation from which they continue to enhance its growth. Cambridge Laboratories is an independent and privately owned company, founded in 1987 and purchased outright by members of the current Board of Directors in 1996.

Cambridge Laboratories is a fast growing, dynamic and entrepreneurial pharmaceutical company with extensive product development and commercialization expertise. Their focus is on specialist pharmaceuticals with core products in Oncology and diseases of the central nervous system (CNS). They have a proven track record in the development, global registration, marketing, sales and distribution of both innovative and well established pharmaceutical products. This combined with its strong product portfolio and their ability to forge lasting relationships with global partners, has helped them generate substantial sales growth over the past 13 years. They are proud of its independence and entrepreneurial culture. Equally, their strong balance sheet and freedom from debt give them a solid foundation from which they continue to enhance its growth. Cambridge Laboratories is an independent and privately owned company, founded in 1987 and purchased outright by members of the current Board of Directors in 1996.

Cambridge Laboratories is a fast growing, dynamic and entrepreneurial pharmaceutical company with extensive product development and commercialization expertise. Their focus is on specialist pharmaceuticals with core products in Oncology and diseases of the central nervous system (CNS). They have a proven track record in the development, global registration, marketing, sales and distribution of both innovative and well established pharmaceutical products. This combined with its strong product portfolio and their ability to forge lasting relationships with global partners, has helped them generate substantial sales growth over the past 13 years. They are proud of its independence and entrepreneurial culture. Equally, their strong balance sheet and freedom from debt give them a solid foundation from which they continue to enhance its growth. Cambridge Laboratories is an independent and privately owned company, founded in 1987 and purchased outright by members of the current Board of Directors in 1996.

Cambridge Laboratories is a fast growing, dynamic and entrepreneurial pharmaceutical company with extensive product development and commercialization expertise. Their focus is on specialist pharmaceuticals with core products in Oncology and diseases of the central nervous system (CNS). They have a proven track record in the development, global registration, marketing, sales and distribution of both innovative and well established pharmaceutical products. This combined with its strong product portfolio and their ability to forge lasting relationships with global partners, has helped them generate substantial sales growth over the past 13 years. They are proud of its independence and entrepreneurial culture. Equally, their strong balance sheet and freedom from debt give them a solid foundation from which they continue to enhance its growth. Cambridge Laboratories is an independent and privately owned company, founded in 1987 and purchased outright by members of the current Board of Directors in 1996.